KEVIN P STARR Insider Trading Transactions
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).
Latest Insider Trading Transactions of KEVIN P STARR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Buy | P | 56.05 | 17,842 | 999,983 | 320,659 | 302.8 K to 320.7 K (+5.89 %) | |
Jun 11 2020 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 168.28 | 24,000 | 4,038,650 | 302,817 | 326.8 K to 302.8 K (-7.34 %) |
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 169.25 | 35,000 | 5,923,600 | 326,817 | 361.8 K to 326.8 K (-9.67 %) |
Mar 07 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
Feb 20 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 510,554 | 0 | 37,362 | 547.9 K to 37.4 K (-93.18 %) |
Jan 05 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.00 | 816,326 | 34,285,774 | 680,272 | 1.5 M to 680.3 K (-54.55 %) |
Dec 08 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 2,885,104 | 4.9 M to 2.9 M (-40.94 %) |
Oct 04 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 40.28 | 75,313 | 3,033,578 | 70,763 | 146.1 K to 70.8 K (-51.56 %) |
Sep 29 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 4,885,104 | 6.9 M to 4.9 M (-29.05 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 400,000 | 17,200,000 | 6,885,104 | 7.3 M to 6.9 M (-5.49 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 201,400 | 8,660,200 | 7,285,104 | 7.5 M to 7.3 M (-2.69 %) |
Sep 27 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 545,000 | 0 | 547,916 | 1.1 M to 547.9 K (-49.87 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.39 | 900 | 38,149 | 7,486,504 | 7.5 M to 7.5 M (-0.01 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 41.00 | 200,350 | 8,214,350 | 7,487,404 | 7.7 M to 7.5 M (-2.61 %) |
Jul 19 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 800,000 | 0 | 1,092,916 | 1.9 M to 1.1 M (-42.26 %) |
Jun 16 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | A | 14.00 | 11,000 | 154,000 | 11,000 | |
Jun 09 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
Apr 14 2017 | CTMX | CytomX Therapeutic ... | STARR KEVIN P | 10% Owner | Sell | S | 16.36 | 28,357 | 463,793 | 31,419 | 59.8 K to 31.4 K (-47.44 %) |
Apr 03 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 850,000 | 0 | 7,687,754 | 8.5 M to 7.7 M (-9.96 %) |
Jan 24 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 1,892,916 | 2.9 M to 1.9 M (-34.57 %) |
Dec 21 2016 | BPMC | Blueprint Medicine ... | STARR KEVIN P | 10% Owner | Sell | S | 28.19 | 106,489 | 3,002,351 | 0 | 106.5 K to 0 (-100.00 %) |
Dec 20 2016 | GBT | Global Blood Thera ... | STARR KEVIN P | 10% Owner | Sell | S | 16.00 | 108,955 | 1,743,345 | 82,544 | 191.5 K to 82.5 K (-56.90 %) |
Dec 01 2016 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 850,000 | 0 | 8,537,754 | 9.4 M to 8.5 M (-9.05 %) |
Sep 07 2016 | EDIT | Editas Medicine, I ... | STARR KEVIN P | 10% Owner | Sell | S | 15.90 | 5,890 | 93,666 | 0 | 5.9 K to 0 (-100.00 %) |
Aug 19 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
Jun 24 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 09 2016 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | A | 13.60 | 11,000 | 149,600 | 11,000 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
May 18 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 9.30 | 25,000 | 232,500 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 15.82 | 25,000 | 395,500 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 11.33 | 12,500 | 141,625 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 11.33 | 12,500 | 141,625 | 12,500 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 103.01 | 900 | 92,708 | 0 | 900 to 0 (-100.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 101.58 | 1,200 | 121,899 | 900 | 2.1 K to 900 (-57.14 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 100.01 | 35,400 | 3,540,478 | 2,100 | 37.5 K to 2.1 K (-94.40 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 15.82 | 25,000 | 395,500 | 37,500 | 12.5 K to 37.5 K (+200.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 11.33 | 12,500 | 141,625 | 12,500 | 0 to 12.5 K |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 109.14 | 3,094 | 337,684 | 0 | 3.1 K to 0 (-100.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 108.23 | 15,499 | 1,677,392 | 3,094 | 18.6 K to 3.1 K (-83.36 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 107.39 | 12,606 | 1,353,760 | 18,593 | 31.2 K to 18.6 K (-40.41 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 106.46 | 4,027 | 428,719 | 31,199 | 35.2 K to 31.2 K (-11.43 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 105.31 | 2,274 | 239,479 | 35,226 | 37.5 K to 35.2 K (-6.06 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 11.33 | 12,500 | 141,625 | 37,500 | 25 K to 37.5 K (+50.00 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 9.30 | 25,000 | 232,500 | 25,000 | 0 to 25 K |
Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 5,500,000 | 0 | 0 | |
Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Buy | C | 0.00 | 1,496,598 | 0 | 1,496,598 | 0 to 1.5 M |
Nov 05 2015 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Buy | C | 0.00 | 8,843,537 | 0 | 9,387,754 | 544.2 K to 9.4 M (+1,625.00 %) |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 98,834 | 0 | 370,323 | 271.5 K to 370.3 K (+36.40 %) |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 476,170 | 0 | 0 | 476.2 K to 0 (-100.00 %) |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 476,170 | 0 | 476,170 | 0 to 476.2 K |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | S | 44.10 | 61,630 | 2,717,883 | 210,371 | 272 K to 210.4 K (-22.66 %) |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | S | 43.73 | 74,949 | 3,277,520 | 272,001 | 347 K to 272 K (-21.60 %) |
Sep 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 1,655,095 | 0 | 346,950 | 2 M to 347 K (-82.67 %) |
Aug 19 2015 | GBT | Global Blood Thera ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 8,000,000 | 0 | 0 | |
Aug 19 2015 | GBT | Global Blood Thera ... | STARR KEVIN P | Director | Option Exercise | C | 0.00 | 41,663,168 | 0 | 0 | |
Aug 19 2015 | GBT | Global Blood Thera ... | STARR KEVIN P | Director | Buy | C | 0.00 | 2,285,713 | 0 | 2,285,713 | 0 to 2.3 M |
Aug 19 2015 | GBT | Global Blood Thera ... | STARR KEVIN P | Director | Buy | C | 0.00 | 11,903,763 | 0 | 12,475,191 | 571.4 K to 12.5 M (+2,083.16 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
Aug 13 2015 | GBT | Global Blood Thera ... | STARR KEVIN P | Director | Option Exercise | A | 20.00 | 15,000 | 300,000 | 15,000 | |
Jul 24 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 99,351 | 0 | 271,489 | 172.1 K to 271.5 K (+57.72 %) |
Jul 24 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 479,081 | 0 | 0 | 479.1 K to 0 (-100.00 %) |
Jul 24 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 479,081 | 0 | 479,081 | 0 to 479.1 K |
Jul 24 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 1,200,000 | 0 | 2,002,045 | 3.2 M to 2 M (-37.48 %) |
Jul 15 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Option Exercise | A | 37.15 | 12,000 | 445,800 | 12,000 | |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
May 29 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
May 18 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 92,041 | 0 | 172,138 | 80.1 K to 172.1 K (+114.91 %) |
May 18 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 443,935 | 0 | 0 | 443.9 K to 0 (-100.00 %) |
May 18 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 443,935 | 0 | 443,935 | 0 to 443.9 K |
May 18 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 3,202,045 | 4.2 M to 3.2 M (-23.80 %) |
Mar 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 71,989 | 0 | 80,097 | 8.1 K to 80.1 K (+887.88 %) |
Mar 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 346,658 | 0 | 0 | 346.7 K to 0 (-100.00 %) |
Mar 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Buy | J | 0.00 | 346,658 | 0 | 346,658 | 0 to 346.7 K |
Mar 25 2015 | ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sell | J | 0.00 | 1,400,000 | 0 | 4,202,045 | 5.6 M to 4.2 M (-24.99 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 27.28 | 25,000 | 682,000 | 0 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 15.91 | 10,000 | 159,100 | 0 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 14.74 | 10,000 | 147,400 | 0 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 15.91 | 15,000 | 238,650 | 10,000 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 14.74 | 10,000 | 147,400 | 10,000 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 7.08 | 20,000 | 141,600 | 0 | |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 79.10 | 900 | 71,188 | 0 | 900 to 0 (-100.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 78.30 | 2,500 | 195,753 | 900 | 3.4 K to 900 (-73.53 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 77.13 | 34,201 | 2,637,968 | 3,400 | 37.6 K to 3.4 K (-90.96 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 76.36 | 7,399 | 564,973 | 37,601 | 45 K to 37.6 K (-16.44 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 27.28 | 25,000 | 682,000 | 45,000 | 20 K to 45 K (+125.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 15.91 | 10,000 | 159,100 | 20,000 | 10 K to 20 K (+100.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 14.74 | 10,000 | 147,400 | 10,000 | 0 to 10 K |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 79.45 | 28,925 | 2,298,198 | 0 | 28.9 K to 0 (-100.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 78.68 | 12,375 | 973,693 | 28,925 | 41.3 K to 28.9 K (-29.96 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 77.48 | 3,700 | 286,666 | 41,300 | 45 K to 41.3 K (-8.22 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 15.91 | 15,000 | 238,650 | 45,000 | 30 K to 45 K (+50.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 14.74 | 10,000 | 147,400 | 30,000 | 20 K to 30 K (+50.00 %) |
Sep 26 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 7.08 | 20,000 | 141,600 | 20,000 | 0 to 20 K |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 30.09 | 25,000 | 752,250 | 25,000 | |
Jun 10 2005 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 7.08 | 10,000 | 70,800 | 20,000 | |
Jun 10 2005 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 7.08 | 10,000 | 70,800 | 10,000 |
Page: 1